Addition of Pyridoxine to Prednisolone in Infantile Spasms
Launched by LADY HARDINGE MEDICAL COLLEGE · Apr 9, 2013
Trial Information
Current as of May 13, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age in 3months-3years.
- • 2. Presence of epileptic spasms (1 or more clusters per day) with EEG evidence of hypsarrythmia or its variants.
- • -
- Exclusion Criteria:
- • 1. Children with active systemic illness
- • 2. Children with evidence of active tuberculosis
- • 3. Severe Acute Malnutrition (standard deviation scores below median weight for height)
- • 4. Children with recurrent illness/chronic systemic illness
- • 5. Prior treatment of pyridoxine, steroid, or ACTH.
- • -
About Lady Hardinge Medical College
Lady Hardinge Medical College is a prestigious medical institution located in New Delhi, India, renowned for its commitment to excellence in medical education, research, and healthcare service delivery. Established in 1916, the college has a rich history of training healthcare professionals and conducting innovative clinical research aimed at advancing medical science and improving patient outcomes. As a sponsor of clinical trials, Lady Hardinge Medical College prioritizes ethical standards, rigorous methodologies, and collaborative partnerships to contribute valuable insights into various medical disciplines, ultimately enhancing the understanding and treatment of diverse health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Delhi, , India
Patients applied
Trial Officials
Satinder Aneja, MD
Principal Investigator
Lady Hardinge Medical College
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials